A, M., T, Z., D, T., M, Y., T, B., & L, E. (2026). Economic Evaluation of NHS England's Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling. PharmacoEconomics - open, 10(2), 289. https://doi.org/10.1007/s41669-025-00622-x
Chicago Style (17th ed.) CitationA, Martin, Zabula T, Tebaldi D, Yang M, Brown T, and Ells L. "Economic Evaluation of NHS England's Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling." PharmacoEconomics - Open 10, no. 2 (2026): 289. https://doi.org/10.1007/s41669-025-00622-x.
MLA (9th ed.) CitationA, Martin, et al. "Economic Evaluation of NHS England's Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling." PharmacoEconomics - Open, vol. 10, no. 2, 2026, p. 289, https://doi.org/10.1007/s41669-025-00622-x.